EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism

Min-Tser Liao, Chia-Chao Wu iD, Yi-Chou Hou, Kuo-Wang Tsai, Li-Jane Shih, Kuo-Cheng Lu, Chien-Lin Lu iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27115094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Min-Tser Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan 32551, Taiwan. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary, Parathyroid Hormone, Bone Remodeling, Parathyroidectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary hyperparathyroidism (SHPT) is a major component of chronic kidney disease–mineral and bone disorder (CKD-MBD), reflecting progressive disturbances in mineral metabolism, endocrine signaling, skeletal remodeling, and parathyroid-gland biology. Traditionally, preoperative parathyroid hormone (PTH) has been used primarily as a biochemical threshold for surgical referral. However, persistent PTH elevation in advanced CKD-related SHPT may reflect more than isolated endocrine activity; available evidence suggests it integrates parathyroid-gland remodeling, receptor resistance, skeletal turnover, treatment refractoriness, and systemic CKD-MBD severity. This review summarizes key molecular and cellular mechanisms of progressive SHPT, including diffuse-to-nodular hyperplastic transition, downregulation of calcium-sensing receptor (CaSR) and vitamin D receptor (VDR) signaling, disruption of the fibroblast growth factor 23 (FGF23)–Klotho axis, and activation of transforming growth factor-α (TGF-α)/epidermal growth factor receptor (EGFR) proliferative pathways. Building on this mechanistic framework, we discuss how persistent PTH elevation has been linked to glandular remodeling, resistance to calcimimetic and vitamin D therapy, high-turnover renal osteodystrophy, hungry bone syndrome, altered intraoperative PTH kinetics, postoperative endocrine–skeletal remodeling, and long-term recurrence. Severe SHPT is also increasingly recognized as a systemic CKD-MBD phenotype associated with vascular calcification, cardiovascular risk, metabolic instability, and impaired quality of life. Within this framework, preoperative PTH is best interpreted as an integrated biomarker within a broader assessment of glandular remodeling, skeletal metabolic activity, endocrine resistance, and systemic CKD-MBD biology, rather than as an isolated biochemical threshold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, SecondaryParathyroid HormoneBone RemodelingParathyroidectomyParathyroid GlandsHumansFibroblast Growth Factor-23BiomarkersAnimals

Stichwörter der Autor:innen

chronic kidney disease–mineral and bone disorderparathyroid gland remodelingparathyroid hormonesecondary hyperparathyroidism

Substanzen

Fibroblast Growth Factor-23Parathyroid HormoneBiomarkersFGF23 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan 32551, Taiwan.
  • Department of Pediatrics, Tri-Service General Hospital, National Defense Medical University, Taipei 11490, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei 11490, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Cardinal-Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
  • Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
  • Department of Medical Laboratory, Taoyuan Armed Forces General Hospital, Taoyuan 32551, Taiwan.

ORCID-Profile: Chia-Chao Wu, Chien-Lin Lu

Zitieren

APA

Liao, M. T., Wu, C. C., Hou, Y. C., Tsai, K. W., Shih, L. J., Lu, K. C., & Lu, C. L. (2026). Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27115094

Vancouver

Liao MT, Wu CC, Hou YC, Tsai KW, Shih LJ, Lu KC, et al. Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27115094

BibTeX
@article{Liao2026,
  author = {Liao, Min-Tser and Wu, Chia-Chao and Hou, Yi-Chou and Tsai, Kuo-Wang and Shih, Li-Jane and Lu, Kuo-Cheng and Lu, Chien-Lin},
  title = {Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27115094}
}
Kostenlos starten →